Upcoming Events
Please visit this page in the coming weeks for additional details.
Ongoing Events
Repositioning existing drugs to treat new diseases - both rare and common - is an attractive prospect to a large contingent of the pharma industry seeking to shorten development timelines and economize development costs. Building on existing research and development efforts means that potentially groundbreaking therapies can achieve approval and reach patients faster, with significant savings for drugs that have already undergone extensive preclinical and clinical safety assessments. However, the process of drug repurposing, whether as a monotherapy or as part of a combination or cocktail, still leads to significant scientific, financial and regulatory challenges, including the reevaluation of dose and dosing regimen along with questions around efficacy with a new patient population. Join our panel of experts who will discuss the challenges of advancing a repurposed drug to market and how to overcome them to achieve strategic success.
FDA Events
Recent meetings are listed on this page. Events held in prior years can be found in the FDA Archive
Past Events
Recognizing and adapting to a new era of global change and uncertainty, DIA's key tenets remain unchanged.
Patients are our story, we seek to understand, collaboration is the skill we hone—and this collaboration must cross organizations, decades, languages, and boundaries to have true global impact.
The DIA 2021 Global Annual Meeting pushes beyond walls and borders. It is collaboration without boundaries, and we want you to join us and play a key role in building the framework of the future—making connections, gaining skills and insights, and advancing science to improve global health.
On behalf of the National Science Foundation, the Department of Biomedical Informatics at Harvard Medical School invites you to the National Symposium on Drug Repurposing for Future Pandemics. The Symposium will bring together leading experts in computer science, biology, statistics, medicine, automation, and regulation to provide a roadmap and put forward recommendations on transforming today’s tools into ready-to-use solutions to fight future pathogens.
Achieve Systematic, Predictable, and Profitable Drug Repositioning & Repurposing Through the use of Advanced AI-driven Tools
AI is making waves across the healthcare industry and holds promise to greatly accelerate drug discovery and development processes. Recent circumstances have provided the perfect opportunity for introducing artificial intelligence in drug repurposing and repositioning, as a faster and more cost-effective way of discovering new therapies in existing drugs. Most repurposed and repositioned drugs fail, but the introduction of AI, coupled with a sound commercial strategy is set to be a game changer.
Join 80+ like-minded peers online in April to discover the AI-driven methodologies driving the most promising drug repositioning and repurposing results, and determine how to make drug repositioning and repurposing a viable and profitable business model at a strategic level.
Featuring real-life case-studies and experiences from companies like BenevolentAI, Teva Pharmaceuticals and Recursion Pharma, as well as interactive panel discussions and virtual roundtables, this is the chance to address your major challenges and find answers to the most pressing AI-driven repositioning and repurposing questions.
Walk away with a toolkit to achieve systematic, predictable, and profitable drug repositioning and repurposing through the use of advanced AI-driven tools
Download the Full Event Guide to get a taste of the real-world case studies you'll be joining at the conference.